INS and Hypoglycemia: Continuous glucose monitoring (CGM) in combination with rapid-acting insulin analogs have improved glucose control, reducing hypoglycemia and episodes of diabetic ketoacidosis (DKA), resulting in more time spent in optimum glucose levels compared to standard monitoring [7].